Cash Flow Statement

Amortizatization of Intangibles Cash from Discontinued Operations Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Non-cash Items Other financing activities Sales of Property, Plant and Equipment Share-based Compensation Shares Issued

Daily Values

Others

Adial Pharmaceuticals (ADIL) Cash from Investing Activities (2023)

Adial Pharmaceuticals' Cash from Investing Activities history spans 1 years, with the latest figure at $350000.0 for Q4 2023.